• First Dose Group in Parkinson’s Stem Cell Trial Successfully Transplanted
  • Phase 1 Study of Voyager’s Gene Therapy Shows Potential for Parkinson’s Patients
  • Trial Data on Rytary and Off Episodes in Advanced Parkinson’s Being Given at AAN
  • Dancing Might Help Prevent Parkinson’s, Recent Research Points Out
  • Adamas to Give Presentations on Treatment for Involuntary Muscle Movements in Parkinson’s
  • MJFF Grant Will Support Mission Therapeutics’ Test of Novel USP30 Therapy in Parkinson’s Models
  • Tiny Changes in Alpha-synuclein Protein Could Be an Important Driver in Parkinson’s, Study Suggests
  • Brain Cells Called Astrocytes Can Be Transformed into Dopamine-producing Neurons, Study Shows
  • Anavex Therapies Reverse Cognitive Defects in Mice, Suggesting Their Use for Parkinson’s
  • Zambon, Valeo Collaborate to Bring Xadago to Canadian Parkinson’s Patients
  • World Parkinson’s Day: Bial Launches ‘Me At My Best’ to Raise Awareness, Help Patients
  • U.S. OKs 23andME Testing the Public for Risk of Parkinson’s, Other Genetic Diseases